Efficacy and Safety of SUBLIVAC Phleum for Immunotherapy of Grass Pollen-Allergy
Clinical trial NCT02556801 · COMPLETED
Trial details
- NCT number
- NCT02556801
- Sponsor
- HAL Allergy
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2016-10-01
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.